“Immunoglobulin Market”

According to Triton’s research report, the immunoglobulin market reached US$13.61 billion in 2021. It is still expected to register a CAGR of 6.77% through 2028.

A recent study by Triton Market Research entitled Global Immunoglobulin Market contains the global market prospects by mode of administration (intramuscular, subcutaneous, intravenous), type (IgA, IgM, IgE, IgD, IgG) and by application (hypogamma-globulemia, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, idiopathic thrombocytopenic purpura, specific antibody deficiency). , Guillain-Barre Syndrome, Primary Immunodeficiency Diseases, Inflammatory Myopathies, Multifocal Motor Neuropathy, Other Applications), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Other Distribution Channels), End-User (Hospitals and Clinics, Home Care), and Geography (North America, Middle East, and Africa , Latin America, Europe, Asia Pacific).

Immunoglobulin helps reduce the risk of life-threatening infections for people with immune-related disorders. In addition, immunoglobulin therapy significantly improves prognosis and quality of life, antibiotic use, promotes better growth of the pediatric population, and maintains normal lung function.

Request Free Sample of Global Immunoglobulin Market Report @ https://www.tritonmarketresearch.com/reports/immunoglobulin-market#request-free-sample

Triton Market Research report shows that the global immunoglobulin market is expected to grow at a CAGR of 6.77% and reach a revenue of US$21.49 billion by 2028.

The incidence of immunodeficiency diseases and the severity of some diseases are more likely to affect the elderly population worldwide. Therefore, the growing geriatric population, the prevalence of immunodeficiency and autoimmune diseases, and increasing R&D activities are expected to increase the demand for immunoglobulin products. This factor, in turn, will complement the market growth during the forecast…